nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivacaftor—CYP3A4—Pilocarpine—glaucoma	0.0898	0.166	CbGbCtD
Ivacaftor—ABCB1—Timolol—glaucoma	0.0861	0.159	CbGbCtD
Ivacaftor—ABCB1—Clonidine—glaucoma	0.0732	0.135	CbGbCtD
Ivacaftor—CYP3A4—Brinzolamide—glaucoma	0.0705	0.13	CbGbCtD
Ivacaftor—CYP3A4—Dorzolamide—glaucoma	0.068	0.126	CbGbCtD
Ivacaftor—CYP3A4—Methazolamide—glaucoma	0.0606	0.112	CbGbCtD
Ivacaftor—CYP3A4—Acetazolamide—glaucoma	0.0485	0.0897	CbGbCtD
Ivacaftor—CYP3A4—Clonidine—glaucoma	0.0438	0.0811	CbGbCtD
Ivacaftor—CFTR—ABC-family proteins mediated transport—PEX19—glaucoma	0.0168	0.437	CbGpPWpGaD
Ivacaftor—Nasal congestion—Brinzolamide—glaucoma	0.00284	0.00676	CcSEcCtD
Ivacaftor—Nasopharyngitis—Bimatoprost—glaucoma	0.00279	0.00662	CcSEcCtD
Ivacaftor—Connective tissue disorder—Latanoprost—glaucoma	0.00273	0.00649	CcSEcCtD
Ivacaftor—Hypoglycaemia—Dorzolamide—glaucoma	0.0027	0.00641	CcSEcCtD
Ivacaftor—Tinnitus—Methazolamide—glaucoma	0.00268	0.00636	CcSEcCtD
Ivacaftor—Oropharyngeal pain—Betaxolol—glaucoma	0.00262	0.00623	CcSEcCtD
Ivacaftor—Hypoglycaemia—Pilocarpine—glaucoma	0.00255	0.00606	CcSEcCtD
Ivacaftor—Myalgia—Metipranolol—glaucoma	0.00254	0.00603	CcSEcCtD
Ivacaftor—Mediastinal disorder—Latanoprost—glaucoma	0.00251	0.00595	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Bimatoprost—glaucoma	0.0025	0.00595	CcSEcCtD
Ivacaftor—Infestation NOS—Apraclonidine—glaucoma	0.00248	0.00588	CcSEcCtD
Ivacaftor—Infestation—Apraclonidine—glaucoma	0.00248	0.00588	CcSEcCtD
Ivacaftor—Nasopharyngitis—Brimonidine—glaucoma	0.00247	0.00586	CcSEcCtD
Ivacaftor—Gynaecomastia—Clonidine—glaucoma	0.00245	0.00582	CcSEcCtD
Ivacaftor—Breast disorder—Brinzolamide—glaucoma	0.00234	0.00556	CcSEcCtD
Ivacaftor—Ear pain—Clonidine—glaucoma	0.00233	0.00554	CcSEcCtD
Ivacaftor—Nasopharyngitis—Brinzolamide—glaucoma	0.00232	0.0055	CcSEcCtD
Ivacaftor—Rhinitis—Apraclonidine—glaucoma	0.00223	0.0053	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Metipranolol—glaucoma	0.00222	0.00527	CcSEcCtD
Ivacaftor—Nasal congestion—Clonidine—glaucoma	0.00218	0.00519	CcSEcCtD
Ivacaftor—Rhinitis—Bimatoprost—glaucoma	0.00216	0.00513	CcSEcCtD
Ivacaftor—Infection—Carbachol—glaucoma	0.00215	0.00511	CcSEcCtD
Ivacaftor—Oropharyngeal pain—Timolol—glaucoma	0.00214	0.00509	CcSEcCtD
Ivacaftor—Connective tissue disorder—Bimatoprost—glaucoma	0.00212	0.00503	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Dorzolamide—glaucoma	0.00212	0.00503	CcSEcCtD
Ivacaftor—Arthralgia—Latanoprost—glaucoma	0.00206	0.0049	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.00205	0.00486	CcSEcCtD
Ivacaftor—Ear pain—Betaxolol—glaucoma	0.00203	0.00482	CcSEcCtD
Ivacaftor—Infestation NOS—Travoprost—glaucoma	0.00202	0.0048	CcSEcCtD
Ivacaftor—Infestation—Travoprost—glaucoma	0.00202	0.0048	CcSEcCtD
Ivacaftor—Mediastinal disorder—Apraclonidine—glaucoma	0.002	0.00476	CcSEcCtD
Ivacaftor—Infestation NOS—Brinzolamide—glaucoma	0.002	0.00474	CcSEcCtD
Ivacaftor—Infestation—Brinzolamide—glaucoma	0.002	0.00474	CcSEcCtD
Ivacaftor—Mediastinal disorder—Bimatoprost—glaucoma	0.00194	0.00462	CcSEcCtD
Ivacaftor—Nervous system disorder—Latanoprost—glaucoma	0.00194	0.0046	CcSEcCtD
Ivacaftor—Skin disorder—Latanoprost—glaucoma	0.00192	0.00456	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00191	0.00455	CcSEcCtD
Ivacaftor—Rhinitis—Brimonidine—glaucoma	0.00191	0.00455	CcSEcCtD
Ivacaftor—Tinnitus—Acetazolamide—glaucoma	0.00185	0.00441	CcSEcCtD
Ivacaftor—Rhinitis—Travoprost—glaucoma	0.00182	0.00432	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Latanoprost—glaucoma	0.0018	0.00428	CcSEcCtD
Ivacaftor—Breast disorder—Clonidine—glaucoma	0.0018	0.00427	CcSEcCtD
Ivacaftor—Rhinitis—Brinzolamide—glaucoma	0.0018	0.00427	CcSEcCtD
Ivacaftor—Connective tissue disorder—Travoprost—glaucoma	0.00178	0.00424	CcSEcCtD
Ivacaftor—Nasopharyngitis—Clonidine—glaucoma	0.00178	0.00422	CcSEcCtD
Ivacaftor—Hypoglycaemia—Betaxolol—glaucoma	0.00177	0.00421	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Methazolamide—glaucoma	0.00176	0.00419	CcSEcCtD
Ivacaftor—Connective tissue disorder—Brinzolamide—glaucoma	0.00176	0.00418	CcSEcCtD
Ivacaftor—CFTR—Transmembrane transport of small molecules—PEX19—glaucoma	0.00176	0.0457	CbGpPWpGaD
Ivacaftor—Rhinitis—Pilocarpine—glaucoma	0.00173	0.0041	CcSEcCtD
Ivacaftor—Mediastinal disorder—Brimonidine—glaucoma	0.00172	0.00409	CcSEcCtD
Ivacaftor—Abdominal pain—Carbachol—glaucoma	0.00171	0.00406	CcSEcCtD
Ivacaftor—Tinnitus—Dorzolamide—glaucoma	0.0017	0.00404	CcSEcCtD
Ivacaftor—Tinnitus—Travoprost—glaucoma	0.00169	0.00402	CcSEcCtD
Ivacaftor—Tinnitus—Brinzolamide—glaucoma	0.00167	0.00397	CcSEcCtD
Ivacaftor—Myalgia—Apraclonidine—glaucoma	0.00165	0.00391	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00164	0.00389	CcSEcCtD
Ivacaftor—Mediastinal disorder—Travoprost—glaucoma	0.00164	0.00389	CcSEcCtD
Ivacaftor—Mediastinal disorder—Brinzolamide—glaucoma	0.00162	0.00384	CcSEcCtD
Ivacaftor—Dizziness—Metipranolol—glaucoma	0.00161	0.00382	CcSEcCtD
Ivacaftor—Tinnitus—Pilocarpine—glaucoma	0.00161	0.00382	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Clonidine—glaucoma	0.0016	0.00379	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00159	0.00377	CcSEcCtD
Ivacaftor—Infection—Apraclonidine—glaucoma	0.00157	0.00373	CcSEcCtD
Ivacaftor—Breast disorder—Betaxolol—glaucoma	0.00156	0.00372	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Betaxolol—glaucoma	0.00156	0.0037	CcSEcCtD
Ivacaftor—Nasal congestion—Timolol—glaucoma	0.00155	0.00369	CcSEcCtD
Ivacaftor—Nervous system disorder—Apraclonidine—glaucoma	0.00155	0.00368	CcSEcCtD
Ivacaftor—Nasopharyngitis—Betaxolol—glaucoma	0.00155	0.00368	CcSEcCtD
Ivacaftor—Rash—Metipranolol—glaucoma	0.00153	0.00365	CcSEcCtD
Ivacaftor—Skin disorder—Apraclonidine—glaucoma	0.00153	0.00364	CcSEcCtD
Ivacaftor—Dermatitis—Metipranolol—glaucoma	0.00153	0.00364	CcSEcCtD
Ivacaftor—Headache—Metipranolol—glaucoma	0.00152	0.00362	CcSEcCtD
Ivacaftor—Infection—Bimatoprost—glaucoma	0.00152	0.00361	CcSEcCtD
Ivacaftor—Nervous system disorder—Bimatoprost—glaucoma	0.0015	0.00357	CcSEcCtD
Ivacaftor—Dizziness—Carteolol—glaucoma	0.00149	0.00354	CcSEcCtD
Ivacaftor—Skin disorder—Bimatoprost—glaucoma	0.00149	0.00353	CcSEcCtD
Ivacaftor—Diarrhoea—Carbachol—glaucoma	0.00148	0.00352	CcSEcCtD
Ivacaftor—ABCB1—ABC-family proteins mediated transport—PEX19—glaucoma	0.00147	0.0382	CbGpPWpGaD
Ivacaftor—Dizziness—Diclofenamide—glaucoma	0.00147	0.00348	CcSEcCtD
Ivacaftor—Diarrhoea—Levobunolol—glaucoma	0.00146	0.00346	CcSEcCtD
Ivacaftor—Hypoglycaemia—Timolol—glaucoma	0.00145	0.00344	CcSEcCtD
Ivacaftor—Nausea—Metipranolol—glaucoma	0.00145	0.00343	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.00144	0.00342	CcSEcCtD
Ivacaftor—Dizziness—Carbachol—glaucoma	0.00143	0.0034	CcSEcCtD
Ivacaftor—Arthralgia—Brimonidine—glaucoma	0.00141	0.00336	CcSEcCtD
Ivacaftor—Myalgia—Brimonidine—glaucoma	0.00141	0.00336	CcSEcCtD
Ivacaftor—Headache—Carteolol—glaucoma	0.00141	0.00336	CcSEcCtD
Ivacaftor—Dizziness—Levobunolol—glaucoma	0.00141	0.00335	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00141	0.00334	CcSEcCtD
Ivacaftor—Rash—Diclofenamide—glaucoma	0.0014	0.00332	CcSEcCtD
Ivacaftor—Diarrhoea—Methazolamide—glaucoma	0.0014	0.00332	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Betaxolol—glaucoma	0.00139	0.0033	CcSEcCtD
Ivacaftor—Headache—Diclofenamide—glaucoma	0.00139	0.0033	CcSEcCtD
Ivacaftor—Rhinitis—Clonidine—glaucoma	0.00138	0.00328	CcSEcCtD
Ivacaftor—Rash—Carbachol—glaucoma	0.00136	0.00324	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00136	0.00324	CcSEcCtD
Ivacaftor—Dermatitis—Carbachol—glaucoma	0.00136	0.00324	CcSEcCtD
Ivacaftor—Headache—Carbachol—glaucoma	0.00136	0.00322	CcSEcCtD
Ivacaftor—Arthralgia—Dorzolamide—glaucoma	0.00135	0.00321	CcSEcCtD
Ivacaftor—Infection—Brimonidine—glaucoma	0.00135	0.0032	CcSEcCtD
Ivacaftor—Arthralgia—Travoprost—glaucoma	0.00135	0.0032	CcSEcCtD
Ivacaftor—Myalgia—Travoprost—glaucoma	0.00135	0.0032	CcSEcCtD
Ivacaftor—Nausea—Carteolol—glaucoma	0.00134	0.00318	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00134	0.00317	CcSEcCtD
Ivacaftor—Headache—Levobunolol—glaucoma	0.00133	0.00317	CcSEcCtD
Ivacaftor—Infestation NOS—Betaxolol—glaucoma	0.00133	0.00317	CcSEcCtD
Ivacaftor—Infestation—Betaxolol—glaucoma	0.00133	0.00317	CcSEcCtD
Ivacaftor—Nervous system disorder—Brimonidine—glaucoma	0.00133	0.00316	CcSEcCtD
Ivacaftor—Arthralgia—Brinzolamide—glaucoma	0.00133	0.00316	CcSEcCtD
Ivacaftor—Myalgia—Brinzolamide—glaucoma	0.00133	0.00316	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00132	0.00314	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00132	0.00313	CcSEcCtD
Ivacaftor—Skin disorder—Brimonidine—glaucoma	0.00132	0.00313	CcSEcCtD
Ivacaftor—Nausea—Diclofenamide—glaucoma	0.00132	0.00313	CcSEcCtD
Ivacaftor—Dizziness—Latanoprost—glaucoma	0.00131	0.0031	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Apraclonidine—glaucoma	0.00129	0.00307	CcSEcCtD
Ivacaftor—Rash—Methazolamide—glaucoma	0.00129	0.00306	CcSEcCtD
Ivacaftor—Dermatitis—Methazolamide—glaucoma	0.00129	0.00305	CcSEcCtD
Ivacaftor—Nausea—Carbachol—glaucoma	0.00129	0.00305	CcSEcCtD
Ivacaftor—Tinnitus—Clonidine—glaucoma	0.00128	0.00305	CcSEcCtD
Ivacaftor—Infection—Travoprost—glaucoma	0.00128	0.00304	CcSEcCtD
Ivacaftor—Headache—Methazolamide—glaucoma	0.00128	0.00304	CcSEcCtD
Ivacaftor—Breast disorder—Timolol—glaucoma	0.00128	0.00304	CcSEcCtD
Ivacaftor—Arthralgia—Pilocarpine—glaucoma	0.00128	0.00303	CcSEcCtD
Ivacaftor—Myalgia—Pilocarpine—glaucoma	0.00128	0.00303	CcSEcCtD
Ivacaftor—Nausea—Levobunolol—glaucoma	0.00127	0.00301	CcSEcCtD
Ivacaftor—Infection—Brinzolamide—glaucoma	0.00127	0.003	CcSEcCtD
Ivacaftor—Nervous system disorder—Travoprost—glaucoma	0.00126	0.003	CcSEcCtD
Ivacaftor—Nasopharyngitis—Timolol—glaucoma	0.00126	0.003	CcSEcCtD
Ivacaftor—Skin disorder—Travoprost—glaucoma	0.00125	0.00298	CcSEcCtD
Ivacaftor—Abdominal pain—Apraclonidine—glaucoma	0.00125	0.00297	CcSEcCtD
Ivacaftor—Nervous system disorder—Brinzolamide—glaucoma	0.00125	0.00297	CcSEcCtD
Ivacaftor—Rash—Latanoprost—glaucoma	0.00125	0.00296	CcSEcCtD
Ivacaftor—Dermatitis—Latanoprost—glaucoma	0.00124	0.00296	CcSEcCtD
Ivacaftor—Mediastinal disorder—Clonidine—glaucoma	0.00124	0.00295	CcSEcCtD
Ivacaftor—Headache—Latanoprost—glaucoma	0.00124	0.00294	CcSEcCtD
Ivacaftor—Skin disorder—Brinzolamide—glaucoma	0.00124	0.00294	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Brimonidine—glaucoma	0.00124	0.00294	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00122	0.0029	CcSEcCtD
Ivacaftor—Infection—Pilocarpine—glaucoma	0.00122	0.00289	CcSEcCtD
Ivacaftor—Nausea—Methazolamide—glaucoma	0.00121	0.00288	CcSEcCtD
Ivacaftor—Rhinitis—Betaxolol—glaucoma	0.0012	0.00285	CcSEcCtD
Ivacaftor—CFTR—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00119	0.0309	CbGpPWpGaD
Ivacaftor—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.00118	0.0028	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Travoprost—glaucoma	0.00117	0.00279	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Brimonidine—glaucoma	0.00117	0.00278	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.00116	0.00276	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Timolol—glaucoma	0.00114	0.0027	CcSEcCtD
Ivacaftor—Tinnitus—Betaxolol—glaucoma	0.00112	0.00265	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00112	0.00265	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Travoprost—glaucoma	0.00111	0.00264	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Brinzolamide—glaucoma	0.0011	0.00261	CcSEcCtD
Ivacaftor—Diarrhoea—Apraclonidine—glaucoma	0.00108	0.00257	CcSEcCtD
Ivacaftor—Mediastinal disorder—Betaxolol—glaucoma	0.00108	0.00256	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Dorzolamide—glaucoma	0.00106	0.00252	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00106	0.00251	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Travoprost—glaucoma	0.00105	0.0025	CcSEcCtD
Ivacaftor—Dizziness—Apraclonidine—glaucoma	0.00104	0.00248	CcSEcCtD
Ivacaftor—Abdominal pain—Dorzolamide—glaucoma	0.00102	0.00243	CcSEcCtD
Ivacaftor—Arthralgia—Clonidine—glaucoma	0.00102	0.00242	CcSEcCtD
Ivacaftor—Abdominal pain—Travoprost—glaucoma	0.00102	0.00242	CcSEcCtD
Ivacaftor—Dizziness—Bimatoprost—glaucoma	0.00101	0.00241	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00101	0.00241	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Pilocarpine—glaucoma	0.001	0.00238	CcSEcCtD
Ivacaftor—Dermatitis—Apraclonidine—glaucoma	0.000995	0.00236	CcSEcCtD
Ivacaftor—Headache—Apraclonidine—glaucoma	0.00099	0.00235	CcSEcCtD
Ivacaftor—Rhinitis—Timolol—glaucoma	0.000981	0.00233	CcSEcCtD
Ivacaftor—Infection—Clonidine—glaucoma	0.000971	0.00231	CcSEcCtD
Ivacaftor—Abdominal pain—Pilocarpine—glaucoma	0.000967	0.0023	CcSEcCtD
Ivacaftor—Diarrhoea—Acetazolamide—glaucoma	0.000967	0.0023	CcSEcCtD
Ivacaftor—Rash—Bimatoprost—glaucoma	0.000966	0.00229	CcSEcCtD
Ivacaftor—Dermatitis—Bimatoprost—glaucoma	0.000965	0.00229	CcSEcCtD
Ivacaftor—Connective tissue disorder—Timolol—glaucoma	0.000961	0.00228	CcSEcCtD
Ivacaftor—Headache—Bimatoprost—glaucoma	0.00096	0.00228	CcSEcCtD
Ivacaftor—Nervous system disorder—Clonidine—glaucoma	0.000958	0.00228	CcSEcCtD
Ivacaftor—Skin disorder—Clonidine—glaucoma	0.000949	0.00226	CcSEcCtD
Ivacaftor—Nausea—Apraclonidine—glaucoma	0.000938	0.00223	CcSEcCtD
Ivacaftor—Dizziness—Acetazolamide—glaucoma	0.000934	0.00222	CcSEcCtD
Ivacaftor—Tinnitus—Timolol—glaucoma	0.000912	0.00217	CcSEcCtD
Ivacaftor—Nausea—Bimatoprost—glaucoma	0.00091	0.00216	CcSEcCtD
Ivacaftor—Dizziness—Brimonidine—glaucoma	0.000897	0.00213	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Clonidine—glaucoma	0.00089	0.00212	CcSEcCtD
Ivacaftor—Arthralgia—Betaxolol—glaucoma	0.000888	0.00211	CcSEcCtD
Ivacaftor—Myalgia—Betaxolol—glaucoma	0.000888	0.00211	CcSEcCtD
Ivacaftor—Diarrhoea—Dorzolamide—glaucoma	0.000886	0.00211	CcSEcCtD
Ivacaftor—Headache—Acetazolamide—glaucoma	0.000885	0.0021	CcSEcCtD
Ivacaftor—Diarrhoea—Travoprost—glaucoma	0.000882	0.0021	CcSEcCtD
Ivacaftor—Mediastinal disorder—Timolol—glaucoma	0.000882	0.00209	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000881	0.00209	CcSEcCtD
Ivacaftor—Diarrhoea—Brinzolamide—glaucoma	0.000871	0.00207	CcSEcCtD
Ivacaftor—Dizziness—Dorzolamide—glaucoma	0.000856	0.00203	CcSEcCtD
Ivacaftor—Rash—Brimonidine—glaucoma	0.000855	0.00203	CcSEcCtD
Ivacaftor—Dermatitis—Brimonidine—glaucoma	0.000854	0.00203	CcSEcCtD
Ivacaftor—Dizziness—Travoprost—glaucoma	0.000853	0.00203	CcSEcCtD
Ivacaftor—Headache—Brimonidine—glaucoma	0.00085	0.00202	CcSEcCtD
Ivacaftor—Infection—Betaxolol—glaucoma	0.000845	0.00201	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Clonidine—glaucoma	0.000844	0.002	CcSEcCtD
Ivacaftor—Dizziness—Brinzolamide—glaucoma	0.000842	0.002	CcSEcCtD
Ivacaftor—Nausea—Acetazolamide—glaucoma	0.000839	0.00199	CcSEcCtD
Ivacaftor—Diarrhoea—Pilocarpine—glaucoma	0.000837	0.00199	CcSEcCtD
Ivacaftor—Nervous system disorder—Betaxolol—glaucoma	0.000834	0.00198	CcSEcCtD
Ivacaftor—Skin disorder—Betaxolol—glaucoma	0.000826	0.00196	CcSEcCtD
Ivacaftor—Rash—Dorzolamide—glaucoma	0.000817	0.00194	CcSEcCtD
Ivacaftor—Dermatitis—Dorzolamide—glaucoma	0.000816	0.00194	CcSEcCtD
Ivacaftor—Rash—Travoprost—glaucoma	0.000813	0.00193	CcSEcCtD
Ivacaftor—Dermatitis—Travoprost—glaucoma	0.000812	0.00193	CcSEcCtD
Ivacaftor—Headache—Dorzolamide—glaucoma	0.000811	0.00193	CcSEcCtD
Ivacaftor—Dizziness—Pilocarpine—glaucoma	0.000809	0.00192	CcSEcCtD
Ivacaftor—Headache—Travoprost—glaucoma	0.000808	0.00192	CcSEcCtD
Ivacaftor—Nausea—Brimonidine—glaucoma	0.000806	0.00191	CcSEcCtD
Ivacaftor—Rash—Brinzolamide—glaucoma	0.000803	0.00191	CcSEcCtD
Ivacaftor—Dermatitis—Brinzolamide—glaucoma	0.000802	0.00191	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Clonidine—glaucoma	0.000799	0.0019	CcSEcCtD
Ivacaftor—Headache—Brinzolamide—glaucoma	0.000798	0.00189	CcSEcCtD
Ivacaftor—CFTR—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000792	0.0206	CbGpPWpGaD
Ivacaftor—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000775	0.00184	CcSEcCtD
Ivacaftor—ALB—HDL-mediated lipid transport—ABCA1—glaucoma	0.000773	0.0201	CbGpPWpGaD
Ivacaftor—Abdominal pain—Clonidine—glaucoma	0.000773	0.00184	CcSEcCtD
Ivacaftor—Rash—Pilocarpine—glaucoma	0.000772	0.00183	CcSEcCtD
Ivacaftor—Dermatitis—Pilocarpine—glaucoma	0.000771	0.00183	CcSEcCtD
Ivacaftor—Nausea—Dorzolamide—glaucoma	0.000769	0.00183	CcSEcCtD
Ivacaftor—Headache—Pilocarpine—glaucoma	0.000767	0.00182	CcSEcCtD
Ivacaftor—Nausea—Travoprost—glaucoma	0.000766	0.00182	CcSEcCtD
Ivacaftor—Nausea—Brinzolamide—glaucoma	0.000756	0.0018	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Betaxolol—glaucoma	0.000735	0.00174	CcSEcCtD
Ivacaftor—Nausea—Pilocarpine—glaucoma	0.000727	0.00173	CcSEcCtD
Ivacaftor—Arthralgia—Timolol—glaucoma	0.000725	0.00172	CcSEcCtD
Ivacaftor—Myalgia—Timolol—glaucoma	0.000725	0.00172	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00072	0.00171	CcSEcCtD
Ivacaftor—Infection—Timolol—glaucoma	0.000691	0.00164	CcSEcCtD
Ivacaftor—Nervous system disorder—Timolol—glaucoma	0.000682	0.00162	CcSEcCtD
Ivacaftor—Skin disorder—Timolol—glaucoma	0.000675	0.0016	CcSEcCtD
Ivacaftor—Diarrhoea—Clonidine—glaucoma	0.000669	0.00159	CcSEcCtD
Ivacaftor—Dizziness—Clonidine—glaucoma	0.000646	0.00154	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Timolol—glaucoma	0.000633	0.0015	CcSEcCtD
Ivacaftor—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000628	0.0163	CbGpPWpGaD
Ivacaftor—Rash—Clonidine—glaucoma	0.000616	0.00146	CcSEcCtD
Ivacaftor—Dermatitis—Clonidine—glaucoma	0.000616	0.00146	CcSEcCtD
Ivacaftor—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000614	0.016	CbGpPWpGaD
Ivacaftor—Headache—Clonidine—glaucoma	0.000612	0.00145	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Timolol—glaucoma	0.0006	0.00143	CcSEcCtD
Ivacaftor—Diarrhoea—Betaxolol—glaucoma	0.000582	0.00138	CcSEcCtD
Ivacaftor—Nausea—Clonidine—glaucoma	0.000581	0.00138	CcSEcCtD
Ivacaftor—CFTR—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000579	0.0151	CbGpPWpGaD
Ivacaftor—Gastrointestinal pain—Timolol—glaucoma	0.000568	0.00135	CcSEcCtD
Ivacaftor—Dizziness—Betaxolol—glaucoma	0.000563	0.00134	CcSEcCtD
Ivacaftor—Abdominal pain—Timolol—glaucoma	0.00055	0.00131	CcSEcCtD
Ivacaftor—Rash—Betaxolol—glaucoma	0.000537	0.00127	CcSEcCtD
Ivacaftor—Dermatitis—Betaxolol—glaucoma	0.000536	0.00127	CcSEcCtD
Ivacaftor—Headache—Betaxolol—glaucoma	0.000533	0.00127	CcSEcCtD
Ivacaftor—ALB—HDL-mediated lipid transport—APOE—glaucoma	0.000508	0.0132	CbGpPWpGaD
Ivacaftor—Nausea—Betaxolol—glaucoma	0.000505	0.0012	CcSEcCtD
Ivacaftor—Diarrhoea—Timolol—glaucoma	0.000476	0.00113	CcSEcCtD
Ivacaftor—Dizziness—Timolol—glaucoma	0.00046	0.00109	CcSEcCtD
Ivacaftor—ALB—Lipoprotein metabolism—ABCA1—glaucoma	0.000444	0.0115	CbGpPWpGaD
Ivacaftor—Rash—Timolol—glaucoma	0.000438	0.00104	CcSEcCtD
Ivacaftor—Dermatitis—Timolol—glaucoma	0.000438	0.00104	CcSEcCtD
Ivacaftor—Headache—Timolol—glaucoma	0.000435	0.00103	CcSEcCtD
Ivacaftor—Nausea—Timolol—glaucoma	0.000413	0.000981	CcSEcCtD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000387	0.0101	CbGpPWpGaD
Ivacaftor—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000361	0.00938	CbGpPWpGaD
Ivacaftor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000352	0.00915	CbGpPWpGaD
Ivacaftor—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000319	0.00829	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—TXN—glaucoma	0.000304	0.0079	CbGpPWpGaD
Ivacaftor—ALB—Lipid and lipoprotein metabolism—ABCA1—glaucoma	0.000295	0.00767	CbGpPWpGaD
Ivacaftor—ALB—Lipoprotein metabolism—APOE—glaucoma	0.000292	0.00759	CbGpPWpGaD
Ivacaftor—ALB—Vitamin B12 Metabolism—ABCA1—glaucoma	0.00029	0.00755	CbGpPWpGaD
Ivacaftor—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000288	0.0075	CbGpPWpGaD
Ivacaftor—ALB—Vitamin B12 Metabolism—SOD1—glaucoma	0.000259	0.00673	CbGpPWpGaD
Ivacaftor—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	0.000242	0.00629	CbGpPWpGaD
Ivacaftor—ALB—Platelet degranulation—TGFB2—glaucoma	0.000238	0.0062	CbGpPWpGaD
Ivacaftor—ALB—Folate Metabolism—ABCA1—glaucoma	0.000236	0.00615	CbGpPWpGaD
Ivacaftor—ALB—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000233	0.00606	CbGpPWpGaD
Ivacaftor—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—glaucoma	0.000227	0.00592	CbGpPWpGaD
Ivacaftor—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.000227	0.0059	CbGpPWpGaD
Ivacaftor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000217	0.00564	CbGpPWpGaD
Ivacaftor—ALB—Folate Metabolism—SOD1—glaucoma	0.000211	0.00548	CbGpPWpGaD
Ivacaftor—ALB—Vitamin B12 Metabolism—MTHFR—glaucoma	0.000205	0.00534	CbGpPWpGaD
Ivacaftor—ALB—Lipid and lipoprotein metabolism—APOE—glaucoma	0.000194	0.00505	CbGpPWpGaD
Ivacaftor—ALB—Lipid and lipoprotein metabolism—CAV1—glaucoma	0.000192	0.005	CbGpPWpGaD
Ivacaftor—ALB—Vitamin B12 Metabolism—APOE—glaucoma	0.000191	0.00497	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—ABCA1—glaucoma	0.000188	0.00488	CbGpPWpGaD
Ivacaftor—ALB—Platelet degranulation—SOD1—glaucoma	0.000181	0.0047	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—PEX19—glaucoma	0.000175	0.00456	CbGpPWpGaD
Ivacaftor—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.000172	0.00447	CbGpPWpGaD
Ivacaftor—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.00017	0.00443	CbGpPWpGaD
Ivacaftor—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000167	0.00435	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—SOD1—glaucoma	0.000167	0.00435	CbGpPWpGaD
Ivacaftor—ALB—Folate Metabolism—MTHFR—glaucoma	0.000167	0.00434	CbGpPWpGaD
Ivacaftor—ALB—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000155	0.00404	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000154	0.004	CbGpPWpGaD
Ivacaftor—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000144	0.00375	CbGpPWpGaD
Ivacaftor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000138	0.00358	CbGpPWpGaD
Ivacaftor—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000136	0.00353	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—MTHFR—glaucoma	0.000133	0.00345	CbGpPWpGaD
Ivacaftor—ABCB1—Allograft Rejection—FAS—glaucoma	0.000128	0.00334	CbGpPWpGaD
Ivacaftor—ABCB1—Allograft Rejection—C3—glaucoma	0.000127	0.00329	CbGpPWpGaD
Ivacaftor—ALB—Platelet degranulation—FN1—glaucoma	0.000126	0.00327	CbGpPWpGaD
Ivacaftor—ALB—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.00012	0.00311	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000118	0.00308	CbGpPWpGaD
Ivacaftor—ALB—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000114	0.00296	CbGpPWpGaD
Ivacaftor—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000112	0.00292	CbGpPWpGaD
Ivacaftor—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000112	0.0029	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000109	0.00282	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000106	0.00275	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000104	0.0027	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000103	0.00267	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NARFL—glaucoma	9.66e-05	0.00251	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CA5A—glaucoma	9.66e-05	0.00251	CbGpPWpGaD
Ivacaftor—ALB—Vitamin B12 Metabolism—TNF—glaucoma	8.83e-05	0.0023	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NARFL—glaucoma	8.46e-05	0.0022	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CA5A—glaucoma	8.46e-05	0.0022	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	8.46e-05	0.0022	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	8.09e-05	0.0021	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	8.01e-05	0.00208	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.9e-05	0.00206	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	7.46e-05	0.00194	CbGpPWpGaD
Ivacaftor—CYP3A4—Biological oxidations—GSTT1—glaucoma	7.44e-05	0.00193	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	7.41e-05	0.00193	CbGpPWpGaD
Ivacaftor—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	7.35e-05	0.00191	CbGpPWpGaD
Ivacaftor—ALB—Platelet degranulation—VEGFA—glaucoma	7.19e-05	0.00187	CbGpPWpGaD
Ivacaftor—ALB—Folate Metabolism—TNF—glaucoma	7.19e-05	0.00187	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.92e-05	0.0018	CbGpPWpGaD
Ivacaftor—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	6.85e-05	0.00178	CbGpPWpGaD
Ivacaftor—ABCB1—Allograft Rejection—VEGFA—glaucoma	6.36e-05	0.00166	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.34e-05	0.00165	CbGpPWpGaD
Ivacaftor—ALB—Folate Metabolism—TP53—glaucoma	6.34e-05	0.00165	CbGpPWpGaD
Ivacaftor—CYP3A4—Biological oxidations—CYP1B1—glaucoma	5.93e-05	0.00154	CbGpPWpGaD
Ivacaftor—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	5.84e-05	0.00152	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.78e-05	0.0015	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—TNF—glaucoma	5.71e-05	0.00149	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	5.57e-05	0.00145	CbGpPWpGaD
Ivacaftor—ABCB1—Allograft Rejection—TNF—glaucoma	5.45e-05	0.00142	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—TGFB2—glaucoma	5.45e-05	0.00142	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.42e-05	0.00141	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CA5A—glaucoma	5.21e-05	0.00136	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NARFL—glaucoma	5.21e-05	0.00136	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.07e-05	0.00132	CbGpPWpGaD
Ivacaftor—CYP3A4—Biological oxidations—GSTM1—glaucoma	4.74e-05	0.00123	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CA1—glaucoma	4.72e-05	0.00123	CbGpPWpGaD
Ivacaftor—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.67e-05	0.00122	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CTSA—glaucoma	4.57e-05	0.00119	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CA2—glaucoma	4.31e-05	0.00112	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.22e-05	0.0011	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.22e-05	0.0011	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CA1—glaucoma	4.13e-05	0.00107	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—SOD1—glaucoma	4.13e-05	0.00107	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CTSA—glaucoma	4e-05	0.00104	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.99e-05	0.00104	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CA2—glaucoma	3.78e-05	0.000983	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.78e-05	0.000982	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	3.19e-05	0.00083	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—MMP1—glaucoma	3.15e-05	0.000819	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.14e-05	0.000817	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—TXN—glaucoma	3.04e-05	0.000791	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—CAV1—glaucoma	3.02e-05	0.000785	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—FN1—glaucoma	2.87e-05	0.000747	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.77e-05	0.000721	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.75e-05	0.000715	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.69e-05	0.0007	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—TXN—glaucoma	2.66e-05	0.000693	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CA1—glaucoma	2.55e-05	0.000662	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CTSA—glaucoma	2.47e-05	0.000641	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.37e-05	0.000617	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTT1—glaucoma	2.36e-05	0.000613	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CA2—glaucoma	2.33e-05	0.000606	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—NOS3—glaucoma	2.28e-05	0.000594	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTT1—glaucoma	2.06e-05	0.000537	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.9e-05	0.000494	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP1B1—glaucoma	1.88e-05	0.000488	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ABCA1—glaucoma	1.88e-05	0.000488	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP1B1—glaucoma	1.65e-05	0.000428	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ABCA1—glaucoma	1.65e-05	0.000428	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—VEGFA—glaucoma	1.64e-05	0.000428	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—TXN—glaucoma	1.64e-05	0.000427	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTM1—glaucoma	1.5e-05	0.00039	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—MTHFR—glaucoma	1.33e-05	0.000345	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTM1—glaucoma	1.32e-05	0.000342	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTT1—glaucoma	1.27e-05	0.000331	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—TP53—glaucoma	1.24e-05	0.000323	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—APOE—glaucoma	1.23e-05	0.000321	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CAV1—glaucoma	1.22e-05	0.000318	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—MTHFR—glaucoma	1.16e-05	0.000302	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—APOE—glaucoma	1.08e-05	0.000281	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CAV1—glaucoma	1.07e-05	0.000279	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ABCA1—glaucoma	1.01e-05	0.000264	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP1B1—glaucoma	1.01e-05	0.000264	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NOS3—glaucoma	9.25e-06	0.000241	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PTGS2—glaucoma	8.46e-06	0.00022	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NOS3—glaucoma	8.11e-06	0.000211	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTM1—glaucoma	8.1e-06	0.000211	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PTGS2—glaucoma	7.41e-06	0.000193	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—MTHFR—glaucoma	7.16e-06	0.000186	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—APOE—glaucoma	6.67e-06	0.000173	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CAV1—glaucoma	6.6e-06	0.000172	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NOS3—glaucoma	4.99e-06	0.00013	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PTGS2—glaucoma	4.57e-06	0.000119	CbGpPWpGaD
